Citadel Advisors
ONEM

Citadel Advisors’s 1Life Healthcare ONEM Stock Holding History

Citadel Advisors’s Portfolio ONEM Stock Details ONEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-81,700
Closed -$1.37M – 16104
2022
Q4 		$1.37M Sell
81,700
-2,500
-3% -$42.2K ﹤0.01% 6222
2022
Q3 		$1.44M Sell
84,200
-96,800
-53% -$1.52M ﹤0.01% 6229
2022
Q2 		$1.42M Buy
181,000
+68,700
+61% +$590K ﹤0.01% 6239
2022
Q1 		$1.24M Sell
112,300
-220,000
-66% -$2.46M ﹤0.01% 7209
2021
Q4 		$5.84M Buy
332,300
+189,200
+132% +$3.67M ﹤0.01% 4032
2021
Q3 		$2.9M Buy
143,100
+3,000
+2% +$77.1K ﹤0.01% 5450
2021
Q2 		$4.63M Buy
140,100
+71,200
+103% +$2.69M ﹤0.01% 4613
2021
Q1 		$2.69M Sell
68,900
-22,900
-25% -$1.08M ﹤0.01% 5703
2020
Q4 		$4.01M Sell
91,800
-38,900
-30% -$1.33M ﹤0.01% 4065
2020
Q3 		$3.71M Buy
130,700
+80,000
+158% +$2.53M ﹤0.01% 3611
2020
Q2 		$1.84M Buy
+50,700
New +$1.43M ﹤0.01% 4729

Citadel Advisors's ONEM Position: Q1 2023 in Review

Citadel Advisors sold out of 1Life Healthcare (ONEM) in Q1 2023, closing a stake of 1,702,490 shares — an estimated $28.4M sold.

Citadel Advisors first reported a position in ONEM in Q1 2020 and held it in 12 quarters. The position peaked at $31.6M in Q4 2020. 0 funds tracked by Wall St. Rank hold ONEM as of Q1 2023.

  • Citadel Advisors reported no remaining 1Life Healthcare position as of Q1 2023 after selling out during the quarter.
  • Citadel Advisors sold 1,702,490 1Life Healthcare shares in Q1 2023, an estimated $28.4M.
  • Citadel Advisors first reported a position in 1Life Healthcare in Q1 2020 and held it in 12 quarters.
  • Citadel Advisors's 1Life Healthcare position peaked at $31.6M in Q4 2020.
  • 0 funds tracked by Wall St. Rank held 1Life Healthcare as of Q1 2023.

Based on Citadel Advisors's 13F filing for Q1 2023, filed 15 May 2023.